Jeffries

Gilead Sciences, Inc. (NASDAQ:GILD) witnessed a flurry of Wall Street speculation regarding its potential involvement in the obesity drug market. But, the biotech company, renowned for its cancer and HIV treatments, has not positioned itself as a contender in this lucrative field. Most recently,...

After over three years of a pandemic-induced pause, federal student loan borrowers are bracing for the resumption of their monthly payments starting in October, potentially resulting in new spending patterns and financial stress for nearly 44 million Americans. According to Jefferies, retailers...

Despite the current housing market downturn and an unpredictable future, paint and coatings giant Sherwin-Williams Co (NYSE:SHW) is positioned to outperform, according to Jefferies. The Analyst: Laurence Alexander upgraded the stock from a Hold to a Buy rating, and raised the price target to $275....

Tesla, Inc. (NASDAQ:TSLA) price cuts have alienated another long-time bull, who dropped his bullish stance and tempered his price target for the stock. The Tesla Analyst: Jefferies analyst Philippe Houchois downgraded Tesla stock from Buy to Hold and reduced the price target from $230 to $185. The...

Canopy Growth (NASDAQ: CGC) announced Tuesday that it is consolidating its U.S. assets into a new holding company to speed up its entry into the U.S. market in which it will hold non-voting/non-participating shares, solving several persistent issues. The...

Costco Wholesale Corporation (NASDAQ: COST) shares rebounded by 1% on Monday after the company reported a fiscal second-quarter earnings beat late last week. Costco reported second-quarter adjusted EPS of $2.92 on revenue of $51.9 billion. Both numbers topped consensus analyst estimates of $2.76...

On CNBC's "Squawk Box Asia," Brent Thill of Jefferies spoke about Facebook, Inc. (NASDAQ: FB). He has a Buy rating for the stock and a price target of $250, but he think it could easily reach $300, with $12 per share earnings and a mid-20 multiple. Thill finds the advertising boycott...

After biotech stocks surged during Thursday’s trading session, Jefferies analyst Maury Raycroft assumed coverage on 6 biotech names he sees as undervalued. While biotech stocks are extremely volatile, these stocks should present a longer-term growth opportunity for investors, according to...

Bristol-Myers Squibb Co (NYSE: BMY) shares spiked 4.5 percent Tuesday on news that Carl Icahn bought a stake in the company. According to the Wall Street Journal, Icahn allegedly considers Bristol-Myers a potential takeover target. Earlier Tuesday, Bristol-Myers reported a $2 billion accelerated...

On Thursday, Church & Dwight Co., Inc. (NYSE: CHD) reported Q2 EPS of $0.85 vs. $0.79 estimates and revenues of $877.4 million vs. estimates of $868.6 million. Jeffries' Take Jeffries' Kevin Grundy applauded Church & Dwight's "strong" earnings report and raised the company's price target...

On June 30, global interconnection giant Equinix Inc (NASDAQ: EQIX) President EMEA Eric Schwartz presented at the NASDAQ Investor Program in London, which was hosted by Jefferies. Earlier this year, $14.7 billion cap Equinix received its formal IRS REIT approval, eclipsing $9.4 billion Digital...

Wayne Farms Inc (NASDAQ: WNFM), the sixth largest producer and processor of broiler chickens, plans to raise over $300 million in its IPO this Thursday. The company is being spun off from parent Continental Grain. Wayne Farms expects to offer over 12.8 million shares between $18 and $21 per share...

Amazon.com, Inc. (NASDAQ: AMZN) broke out results for its Web Services unit Thursday, with results that pleased investors. Web Services revenue grew 49 percent in the recent period to $1.57 billion, while its operating income fell 13 percent (excluding foreign exchange effects). Total Amazon...